Beta Bionics Announces Closing of $57 Million Series C Financing
![](http://startup-investment-review.com/wp-content/uploads/2022/02/betabionics-1024x535.jpg)
Beta Bionics, Inc. — a clinical stage medical technology company committed to the design, development, and commercialization of the iLet® Bionic Pancreas System — today announced the completion of a $57 million Series C equity financing. Proceeds from the financing will support product development, regulatory submissions, and preparations for the commercialization of the insulin dosing […]